TearLab Corporation reported unaudited consolidated financial results for the first quarter ended March 31, 2018. For the three months ended March 31, 2018, TearLab’s net revenues were $6.4 million, a decrease of 3.8% from $6.7 million for the same period in 2017. The company’s reported net loss for the first quarter was approximately $0.9 million, or $0.09 basic loss per share which included a pre-tax reduction of approximately $0.5 million in cost of goods sold related to the Restated License Agreement with UCSD. This compared to a reported net loss of approximately $4.4 million, or $0.82 basic loss per share in the first quarter of 2017. Gain from operations was $217,000 against loss of $3.39 million for the same period in 2017.